BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1706 related articles for article (PubMed ID: 10627428)

  • 1. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
    Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
    Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Anticentromere Antibodies With More Severe Exocrine Glandular Dysfunction in Sjögren's Syndrome: Analysis of the Sjögren's International Collaborative Clinical Alliance Cohort.
    Baer AN; Medrano L; McAdams-DeMarco M; Gniadek TJ
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1554-9. PubMed ID: 26867144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of salivary gland focus score in the diagnosis of Sjögren's syndrome].
    Fei YY; Li XM; Lin DF; Li MT; Zhang W; Zhang X; Zhao Y; Zeng XF; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(13):976-9. PubMed ID: 23886258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
    Toker E; Yavuz S; Direskeneli H
    Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
    Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
    Gerli R; Muscat C; Giansanti M; Danieli MG; Sciuto M; Gabrielli A; Fiandra E; Vitali C
    Br J Rheumatol; 1997 Sep; 36(9):969-75. PubMed ID: 9376993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between autoantibody types and salivary gland hypofunction in patients with primary Sjögren's syndrome.
    Kim BE; Kwon JS; Choi JH; Park PG; Ahn HJ
    J Oral Pathol Med; 2023 Feb; 52(2):188-194. PubMed ID: 36183157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.
    Ben-Chetrit E; Fischel R; Rubinow A
    Clin Rheumatol; 1993 Dec; 12(4):471-4. PubMed ID: 8124907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fodrin autoantibodies are reliable diagnostic markers for juvenile and adult Sjogren's syndrome.
    Lawind MF; Alyasky A; Elwan NM; Mourad H; Al-Bendary A
    Egypt J Immunol; 2004; 11(1):75-81. PubMed ID: 15724389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren's Syndrome.
    Stone DU; Fife D; Brown M; Earley KE; Radfar L; Kaufman CE; Lewis DM; Rhodus NL; Segal BM; Wallace DJ; Weisman MH; Venuturupalli S; Brennan MT; Lessard CJ; Montgomery CG; Scofield RH; Sivils KL; Rasmussen A
    PLoS One; 2017; 12(2):e0170249. PubMed ID: 28166540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome.
    Mofors J; Holmqvist M; Westermark L; Björk A; Kvarnström M; Forsblad-d'Elia H; Magnusson Bucher S; Eriksson P; Theander E; Mandl T; Wahren-Herlenius M; Nordmark G
    J Intern Med; 2019 Oct; 286(4):458-468. PubMed ID: 31127862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
    Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
    J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of antibodies and minor salivary gland biopsy in the study of sicca syndrome in daily clinical practice.
    Santiago ML; Seisdedos MR; Garcia Salinas RN; Catalán Pellet A; Villalón L; Secco A
    Reumatol Clin; 2015; 11(3):156-60. PubMed ID: 25579246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren's syndrome.
    Gál I; Lakos G; Zeher M
    Autoimmunity; 2000 Sep; 32(2):89-92. PubMed ID: 11078154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants.
    Daniels TE; Cox D; Shiboski CH; Schiødt M; Wu A; Lanfranchi H; Umehara H; Zhao Y; Challacombe S; Lam MY; De Souza Y; Schiødt J; Holm H; Bisio PA; Gandolfo MS; Sawaki T; Li M; Zhang W; Varghese-Jacob B; Ibsen P; Keszler A; Kurose N; Nojima T; Odell E; Criswell LA; Jordan R; Greenspan JS;
    Arthritis Rheum; 2011 Jul; 63(7):2021-30. PubMed ID: 21480190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower prevalence of extra-glandular manifestations and anti-SSB antibodies in patients with primary Sjögren's syndrome and widespread pain: evidence for a relatively benign subset.
    ter Borg EJ; Kelder JC
    Clin Exp Rheumatol; 2014; 32(3):349-53. PubMed ID: 24529195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 86.